Polygenic Risk Scores for Prostate Cancer Risk Stratification - Lessons From the BARCODE1 Study

Wednesday, January 27, 2027 at 12:30 PM to 1:00 PM · 30 min. (Europe/London)
Cancer Diagnostics Stage
Day 1 - Wednesday 27th January
CancerDiagnosticsPolygenic Risk ScoresPrecision Medicine

Information

This session will cover: 

  • The latest evidence supporting the use of polygenic risk scores for prostate cancer risk stratification. 
  • Key findings from the BARCODE1 study and what they reveal about targeted screening approaches. 
  • How genetic risk stratification could improve targeting of early detection and assessment of overdiagnosis 
  • The opportunities and challenges associated with integrating polygenic risk scores into routine healthcare. 
  • What long-term follow-up data can tell us about the clinical utility of risk-based prostate cancer screening.